This is the authors' abstract. We don't add key points for this paper.
The development of new genetic medicines to treat sickle cell disease highlights the need for greater collaboration between researchers and people with lived experiences. Drawing on the adage "Nothing about us, without us," we call for increased investments in community advocacy and engagement.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Olayiwola et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: